↓ Skip to main content

Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability

Overview of attention for article published in Cancer Gene Therapy, September 2011
Altmetric Badge

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability
Published in
Cancer Gene Therapy, September 2011
DOI 10.1038/cgt.2011.58
Pubmed ID
Authors

W Gu, E Yeo, N McMillan, C Yu

Abstract

Accumulating evidence supports the concept that cancer stem cells (CSCs) are responsible for tumor initiation and maintenance. They are also considered as an attractive target for advanced cancer therapy. Using a sphere culture method that favors the growth of self-renewal cells, we have isolated sphere-forming cells (SFCs) from cervical cancer cell lines HeLa and SiHa. HeLa-SFCs were resistant to multiple chemotherapeutic drugs and were more tumorigenic, as evidenced by the growth of tumors following injection of immunodeficient mice with 1 × 10(4) cells, compared with 1 × 10(6) parental HeLa cells required to grow tumors of similar size in the same time frame. These cells showed an expression pattern of CD44(high)/CD24(low) that resembles the CSC surface biomarker of breast cancer. We further demonstrated that HeLa-SFCs expressed a higher level (6.9-fold) of the human papillomavirus oncogene E6, compared with that of parental HeLa cells. Gene silencing of E6 with a lentiviral-short-hairpin RNA (shRNA) profoundly inhibited HeLa-SFC sphere formation and cell growth. The inhibition of cell growth was even greater than that for sphere formation after E6 silence, suggesting that the loss of self-renewing ability may be more important. We then measured the expression of self-renewal genes, transformation growth factor-beta (TGF-β) and leukemia-inhibitory factor (LIF), in shRNA-transduced HeLa-SFCs and found that expression of all three TGF-β isoforms was significantly downregulated while LIF remained unchanged. Expression of the Ras gene (a downstream component of TGF-β) was also markedly decreased, suggesting that the growth-inhibitory effect could be via the TGF-β pathway. The above data indicate RNA interference-based therapy may offer a new approach for CSC-targeted cancer therapy.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 2%
Argentina 1 2%
Unknown 58 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 20%
Student > Bachelor 11 18%
Researcher 10 17%
Student > Master 7 12%
Student > Postgraduate 5 8%
Other 11 18%
Unknown 4 7%
Readers by discipline Count As %
Medicine and Dentistry 17 28%
Agricultural and Biological Sciences 14 23%
Biochemistry, Genetics and Molecular Biology 10 17%
Immunology and Microbiology 3 5%
Psychology 2 3%
Other 8 13%
Unknown 6 10%